Company Description
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada.
It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women’s pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.
It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations.
In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors.
Further, it provides medical technology services, such as telemedicine and remote patient monitoring; develops and distributes personalized health and wellness product solutions; and operates corporate-owned clinics.
The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017.
The company is headquartered in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.
| Country | United States |
| Founded | 2000 |
| IPO Date | Sep 22, 2017 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 230 |
| CEO | Robert Mattacchione |
Contact Details
Address: 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 United States | |
| Phone | 206 617 9797 |
| Website | novointegrated.com |
Stock Details
| Ticker Symbol | NVOS |
| Exchange | NASDAQ |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| CIK Code | 0001138978 |
| CUSIP Number | 67011T201 |
| ISIN Number | US67011T3005 |
| Employer ID | 59-3691650 |
| SIC Code | 3510 |
Key Executives
| Name | Position |
|---|---|
| Robert Mattacchione | Chairman of the Board and Chief Executive Officer |
| Christopher Mehlin David | Chief Operating Officer and Director |
| Robert Letterio Oliva | President |
| Dr. Joseph M. Chalil FACHE, M.B.A., M.D. | Chief Medical Officer and Chairman of Medical Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 15, 2024 | 8-K | Current Report |
| Jul 19, 2024 | 10-Q | Quarterly Report |
| Jul 19, 2024 | 8-K | Current Report |
| Jul 18, 2024 | 8-K | Current Report |
| Jul 15, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Jul 8, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jun 27, 2024 | 8-K | Current Report |
| Jun 25, 2024 | 8-K | Current Report |
| Jun 13, 2024 | 8-K | Current Report |
| Jun 6, 2024 | 8-K | Current Report |